|
Gerry Wright and Eric Brown, biochemistry.
Gerry Wright and Eric Brown
Outwitting microbes by designing novel antibiotics is a key
goal of biochemists Dr. Gerry Wright, Canada Research Chair in Molecular
Studies of Antibiotics and Dr. Eric Brown, Canada Research Chair
in Antimicrobial Research.
|
 |
 |
Working out of the new McMaster High Throughput Screening
Laboratory – a $15 million facility which screens compounds
against bacterial targets as well as anti-AIDS and anti-cancer
targets – the researchers are searching for new routes
to the design of truly novel antibiotics.
Brown says that only one new class of antibiotics has reached
the clinic in the last 30 years, yet, during that same period,
there has been an alarming increase of reports of “superbugs”with
resistance to existing antibiotics. Their goal: to find new
chinks in the armour of bacteria.
<
BACK TO FACES
OF INNOVATION
|
|
